Protara Therapeutics

About Protara Therapeutics

Protara Therapeutics is a biotechnology company focused on developing transformative therapies for various medical conditions. Their mission is to search tenaciously for innovative treatments to address unmet needs in healthcare.

Products & Services

TARA-002:A lead investigational cell therapy based on the immunopotentiator OK-432, approved in Japan and Taiwan for oncologic indications and lymphatic malformations (LMs). It is being evaluated in the U.S. for non-muscle invasive bladder cancer (NMIBC) and LMs, with Rare Pediatric Disease Designation by the FDA.

IV Choline Chloride:An investigational phospholipid substrate replacement therapy for patients on parenteral support (PS). It aims to address choline deficiency and liver damage in PS patients, with potential to be the first FDA-approved IV choline formulation.

Specialties

Cell Therapy Immunotherapy Non-Muscle Invasive Bladder Cancer (NMIBC) Lymphatic Malformations (LMs) Parenteral Support Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 75000000 MR: - FA: approximately $75 million FAN: 75000000	D: 2025-12-08 FD: 2025-12-08	5 investors
2	RT: Public Offering T: - FT: Public Offering	A: 75000000 MR: - FA: $75 million FAN: 75000000	D: 2025-12-04 FD: 2025-12-04	3 investors
3	RT: Public Offering T: - FT: Public Offering	A: 100000000 MR: - FA: $100 million FAN: 100000000	D: 2024-12-11 FD: 2024-12-11	5 investors
4	RT: Public Offering T: - FT: Public Offering	A: 100000000 MR: - FA: $100 million FAN: 100000000	D: 2024-12-09 FD: 2024-12-09	5 investors
5	RT: Private Placement T: - FT: Private Placement	A: 45000000 MR: - FA: approximately $45 million FAN: 45000000	D: 2024-04-05 FD: 2024-04-05	9 investors

Public Offering Latest

2025-12-08

$75.0M

5 investors (Pro only)

Public Offering 2025-12-04

$75.0M

Public Offering 2024-12-11

$100.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News